|
AIM Aim Immunotech Inc 946644 |
| Income Statement |
|
Revenue
|
form10-q
|
35,000 |
|
Net Income
|
form10-q
|
-3,700,000 |
|
Profit Margin
|
|
-10571.43% |
| Balance Sheet |
|
Current Assets
|
7,570,000 |
|
Assets
|
13,588,000 |
|
Current Liabilities
|
10,100,000 |
|
Liabilities
|
10,676,000 |
|
Equity
|
2,912,000 |
|
Shares Out
|
57,137,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-10,933,000 |
|
Investing Cash Flow
|
1,002,000 |
| Market Analysis |
Market Cap
|
18,117,421 |
|
Price
|
0.12 |
|
BVPS
|
0.05 |
|
PB
|
2.35 |
|
EPS
|
-0.57 |
|
PS
|
129.41 |
|
FCF
|
-9,931,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AIM documents filed with the SEC.
AIM Filings
Clear
